By Admin at 12 Jan 2017

A Gateway-funded clinical trial is making big news for breakthrough success in brain cancer. For the first time, researchers have successfully used a form of immunotherapy, which harnesses a patient’s own immune system to fight cancer, to treat an aggressive type of brain tumor called glioblastoma.